|
|
|
Insider
Information: |
Shafer Bradford J |
Relationship: |
EVP, Gen. Counsel, Sec... |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
720,844 |
|
Indirect Shares
|
8,250 |
|
|
Direct
Value |
$9,834,001 |
|
|
Indirect Value
|
$133,568 |
|
|
Total
Shares |
729,094 |
|
|
Total
Value |
$9,967,569 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
Sr VP, Gen. Counsel, S... |
2014-08-20 |
443,013 |
2014-08-12 |
8,250 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
EVP, Gen. Counsel, Sec... |
2021-08-20 |
277,831 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
103 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-02-20 |
4 |
D |
$29.09 |
$162,526 |
D/D |
(5,587) |
130,661 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2019-02-20 |
4 |
D |
$27.00 |
$156,546 |
D/D |
(5,798) |
183,446 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-08-07 |
4 |
S |
$28.03 |
$168,393 |
D/D |
(5,945) |
123,479 |
0 |
- |
|
INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
|
2011-03-11 |
4 |
S |
$22.75 |
$146,760 |
I/I |
(6,451) |
0 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-08-20 |
4 |
D |
$26.95 |
$188,785 |
D/D |
(7,005) |
91,119 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-11-20 |
4 |
D |
$24.79 |
$173,679 |
D/D |
(7,006) |
76,994 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2017-05-20 |
4 |
D |
$36.83 |
$260,720 |
D/D |
(7,079) |
156,076 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2017-08-20 |
4 |
D |
$27.40 |
$193,965 |
D/D |
(7,079) |
148,997 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2017-11-20 |
4 |
D |
$28.58 |
$202,318 |
D/D |
(7,079) |
127,248 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-08-27 |
4 |
S |
$27.71 |
$197,282 |
D/D |
(7,119) |
84,000 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2016-08-18 |
4 |
S |
$28.55 |
$204,818 |
D/D |
(7,174) |
241,686 |
0 |
- |
|
INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
|
2007-08-01 |
4 |
S |
$26.00 |
$191,672 |
D/D |
(7,300) |
264,435 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Sr VP, Gen. Counsel, Secretary |
|
2015-06-02 |
4 |
D |
$13.83 |
$101,789 |
D/D |
(7,360) |
156,953 |
0 |
- |
|
INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
|
2004-10-05 |
4 |
B |
$16.00 |
$132,000 |
I/I |
8,250 |
2,750 |
1.99 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
200,722 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
136,248 |
0 |
- |
|
INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
|
2012-02-20 |
4 |
D |
$18.54 |
$178,373 |
D/D |
(9,621) |
346,052 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-06-06 |
4 |
S |
$24.09 |
$244,268 |
D/D |
(10,140) |
133,324 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2017-02-20 |
4 |
D |
$33.78 |
$420,223 |
D/D |
(12,440) |
188,282 |
0 |
- |
|
INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
|
2010-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
260,077 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2017-09-06 |
4 |
S |
$30.77 |
$451,350 |
D/D |
(14,670) |
134,327 |
0 |
- |
|
INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
|
2007-08-01 |
4 |
S |
$25.73 |
$419,431 |
D/D |
(16,200) |
248,235 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Sr VP, Gen. Counsel, Secretary |
|
2016-02-20 |
4 |
D |
$15.65 |
$296,098 |
D/D |
(18,920) |
136,165 |
0 |
- |
|
INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
|
2011-11-28 |
4 |
AS |
$21.00 |
$420,000 |
D/D |
(20,000) |
350,673 |
0 |
- |
|
INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
|
2011-03-11 |
4 |
S |
$22.76 |
$460,617 |
D/D |
(20,238) |
346,825 |
0 |
- |
|
103 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|